Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
202
天
History of gastrointestinal symptoms with other glucose‐lowering agents is associated with gastrointestinal adverse events after imeglimin initiation: A retrospective real‐world study
作者
Kodai Yoshida; Yukiko Onishi; Tetsuya Kubota; Yoko Yoshida; Tazu Tahara; Satoru Takase; Masahiko Iwamoto; Ryusuke Nakada; Hikaru Aita; Masato Kasuga展开收起
作者单位
1. The Institute of Medical Science, Asahi Life Foundation Tokyo Japan; 2. Chiba Rosai Hospital Chiba Japan展开收起
64
天
Association between the cholesterol‐high‐density lipoprotein‐glucose index and the incidence of new‐onset diabetes in patients with chronic gastrointestinal diseases: A prospective cohort study
作者
Liyan lv; Juhua Wu; Xiaoqing Lin; Shiqian Lan; Yinping Sun展开收起
作者单位
1. Digestive Medicine Center Longyan First Affiliated Hospital of Fujian Medical University Longyan Fujian China; 2. Department of Anesthesiology Longyan First Affiliated Hospital of Fujian Medical University Longyan Fujian China展开收起
62
天
Association between thyroid feedback quantile‐based index and the risk of in‐hospital amputation in patients with diabetic foot ulcer
作者
Jiale Wang; Yujie Huang; Funeng Wang; Meiling Lao; Lijun Lan; Peiling Liang展开收起
作者单位
1. The Eighth Clinical Medical College of Guangzhou University of Chinese Medicine Foshan Guangdong China; 2. Foshan Hospital of Traditional Chinese Medicine Foshan Guangdong China展开收起
41
天
82
天
Intensified multifactorial intervention leads to long‐term benefit on kidney outcomes in advanced diabetic kidney disease: A 10‐year follow‐up of the DNETT ‐Japan trial
作者
Kenichi Shikata; Satoshi Miyamoto; Masakazu Haneda; Hiroki Hosoi; Kota Sakamoto; Yoshiki Suzuki; Daisuke Suzuki; Hitoshi Ishida; Hiroaki Akai; Yasuhiko Tomino; Takashi Uzu; Motonobu Nishimura; Hiromi Kuramoto; Michihiro Yoshida; Daisuke Ogawa; Toshiharu Ninomiya; Hirofumi Makino; the Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT‐Japan) collaborative group展开收起
作者单位
1. Okayama University Okayama Japan; 2. Center for Innovative Clinical Medicine, Medical Development Field Okayama University Okayama Japan; 3. Asahikawa Medical University Asahikawa Japan; 4. Center for Innovative Clinical Medicine Okayama University Hospital Okayama Japan; 5. Division of Clinical Nephrology and Rheumatology Niigata University Medical and Dental Hospital Niigata Japan; 6. Suzuki Diabetes Clinic Atsugi Japan; 7. Research Center for Health Care Nagahama City Hospital Nagahama Japan; 8. Division of Diabetes and Metabolism, Faculty of Medicine Tohoku Medical and Pharmaceutical University Sendai Japan; 9. Department of Nephrology Juntendo University Faculty of Medicine Hongo, Bunkyo‐Ku Tokyo Japan; 10. Division of Nephrology, Department of Medicine Nippon Life Hospital Osaka Japan; 11. Department of Endocrinology and Metabolism NHO Chiba Medical Center Chibahigashi National Hospital Chiba Japan; 12. Okayama Diabetes and Neurology Clinic Okayama Japan; 13. Department of Epidemiology and Public Health, Graduate School of Medical Sciences Kyushu University Fukuoka Japan展开收起
122
天
Insulin‐reducing effect of adding imeglimin to ongoing dipeptidyl peptidase‐4 inhibitor therapy with multiple daily insulin injections ( INSPIRE study)
作者
Atsushi Itsukaichi; Fukumi Yoshikawa; Manabu Saito; Ayako Fuchigami; Yoko Iwata; Genki Sato; Hiroshi Uchino; Takahisa Hirose展开收起
作者单位
1. Department of Diabetes, Metabolism and Endocrinology Toho University Graduate School of Medicine Tokyo Japan展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
